To further compare our predictive model with well-established AD biomarkers, we analyzed plasma ptau181, ptau217, Aβ40, Aβ42, NEFL, and GFAP measured using the Alamar/Nulisa platform30 in the same samples. This evidence concerns the gene GFAP and Alzheimer disease.